Role of the deubiquitinating enzyme ubiquitin-specific protease-14 in proteostasis in renal cells

American Journal of Physiology - Renal Physiology

Volumn 311, Issue 5, 2016, Pages F1035-F1046

  Sareen Khanna, Kapil ^a   Papillon, Joan ^a   Wing, Simon S ^a   Cybulsky, Andrey V ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cell injury; Complement; Cytotoxicity; Nephrin; Proteasome

Indexed keywords

ACTIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CD3 ANTIGEN; COMPLEMENT COMPONENT C5B; COMPLEMENTARY DNA; DEUBIQUITINASE; GLUCOSE REGULATED PROTEIN 94; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; NEPHRIN; REACTIVE OXYGEN METABOLITE; TUNICAMYCIN; UBIQUITIN SPECIFIC PROTEASE 14; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; COMPLEMENT; PROTEASOME; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME RELEASE; GLOMERULUS EPITHELIUM CELL; HEK293 CELL LINE; HUMAN; HUMAN CELL; KIDNEY CELL; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; PROTEIN MISFOLDING; RAT; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; EPITHELIUM CELL; GLOMERULUS; METABOLISM; REPERFUSION INJURY;

COMPLEMENT SYSTEM PROTEINS; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; KIDNEY GLOMERULUS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; REPERFUSION INJURY; UBIQUITIN THIOLESTERASE;

EID: 84995449808     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00252.2016     Document Type: Article

References (43)

1. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695: 189-207, 2004.
2. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555, 2001.
3. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011.
4. Borodovsky A, Kessler BM, Casagrande R, Overkleeft HS, Wilkinson KD, Ploegh HL. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 20: 5187-5196, 2001.
5. Brodsky JL, Skach WR. Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr Opin Cell Biol 23: 464-475, 2011.
6. Chen PC, Qin LN, Li XM, Walters BJ, Wilson JA, Mei L, Wilson SM. The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J Neurosci 29: 10909-10919, 2009.
7. Coers W, Reivinen J, Miettinen A, Huitema S, Vos JT, Salant DJ, Weening JJ. Characterization of a rat glomerular visceral epithelial cell line. Exp Nephrol 4: 184-192, 1996.
8. Cybulsky AV. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 77: 187-193, 2010.
9. Cybulsky AV. The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int 84: 25-33, 2013.
10. Cybulsky AV. Membranous nephropathy. Contrib Nephrol 169: 107-125, 2011.
11. Cybulsky AV, Takano T, Papillon J, Bijian K. Role of the endoplasmic reticulum unfolded protein response in glomerular epithelial cell injury. J Biol Chem 280: 24396-24403, 2005.
12. Cybulsky AV, Takano T, Papillon J, Khadir A, Liu J, Peng H. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. J Biol Chem 277: 41342-41351, 2002.
13. D’Arcy P, Brnjic S, Olofsson MH, Fryknas M, Lindsten K, De Cesare M, Perego P, Sadeghi B, Hassan M, Larsson R, Linder S. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med 17: 1636-1640, 2011.
14. Dantuma NP, Lindsten K. Stressing the ubiquitin-proteasome system. Cardiovasc Res 85: 263-271, 2010.
15. Drozdova T, Papillon J, Cybulsky AV. Nephrin missense mutations: induction of endoplasmic reticulum stress and cell surface rescue by reduction in chaperone interactions. Physiol Rep 1: e00086, 2013.
16. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477-513, 2009.
17. Gilon T, Chomsky O, Kulka RG. Degradation signals recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair. Mol Cell Biol 20: 7214-7219, 2000.
18. Glickman MH, Rubin DM, Fried VA, Finley D. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol 18: 3149- 3162, 1998.
19. Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, Kirkpatrick DS, Leggett DS, Gygi SP, King RW, Finley D. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127: 99-111, 2006.
20. Heideker J, Wertz IE. DUBs, the regulation of cell identity and disease. Biochem J 465: 1-26, 2015.
21. Hu M, Li P, Song L, Jeffrey PD, Chenova TA, Wilkinson KD, Cohen RE, Shi Y. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J 24: 3747-3756, 2005.
22. Inagi R. Endoplasmic reticulum stress as a progression factor for kidney injury. Curr Opin Pharmacol 10: 156-165, 2010.
23. Kitzler TM, Papillon J, Guillemette J, Wing SS, Cybulsky AV. Complement modulates the function of the ubiquitin-proteasome system and endoplasmic reticulum-associated degradation in glomerular epithelial cells. Biochim Biophys Acta 1823: 1007-1016, 2012.
24. Koulich E, Li X, DeMartino GN. Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol Biol Cell 19: 1072-1082, 2008.
25. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17: 1807-1819, 2006.
26. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, Gartner C, Dimova N, Hanna J, Gygi SP, Wilson SM, King RW, Finley D. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467: 179-184, 2010.
27. Lee BH, Lu Y, Prado MA, Shi Y, Tian G, Sun S, Elsasser S, Gygi SP, King RW, Finley D. USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites. Nature 532: 398-401, 2016.
28. Lee MJ, Lee BH, Hanna J, King RW, Finley D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteomics 10: R110003871, 2011.
29. Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestila M, Tryggvason K. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64: 51-61, 1999.
30. Leu JI, Pimkina J, Pandey P, Murphy ME, George DL. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 9: 936-947, 2011.
31. Liu L, Done SC, Khoshnoodi J, Bertorello A, Wartiovaara J, Berggren PO, Tryggvason K. Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum Mol Genet 10: 2637-2644, 2001.
32. Menendez-Benito V, Verhoef LG, Masucci MG, Dantuma NP. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum Mol Genet 14: 2787-2799, 2005.
33. Meyer-Schwesinger C, Meyer TN, Sievert H, Hoxha E, Sachs M, Klupp EM, Munster S, Balabanov S, Carrier L, Helmchen U, Thaiss F, Stahl RA. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am J Pathol 178: 2044-2057, 2011.
34. Mimnaugh EG, Chen HY, Davie JR, Celis JE, Neckers L. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry 36: 14418-14429, 1997.
35. Nezvitsky L, Tremblay ML, Takano T, Papillon J, Cybulsky AV. Complement-mediated glomerular injury is reduced by inhibition of protein-tyrosine phosphatase 1B. Am J Physiol Renal Physiol 307: F634- F647, 2014.
36. Ortuno D, Carlisle HJ, Miller S. Does inactivation of USP14 enhance degradation of proteasomal substrates that are associated with neurodegenerative diseases? F1000Res 5: 137, 2016.
37. Pickart CM. Ubiquitin in chains. Trends Biochem Sci 25: 544-548, 2000.
38. Quigg RJ, Cybulsky AV, Jacobs JB, Salant DJ. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int 34: 43-52, 1988.
39. Takano T, Elimam H, Cybulsky AV. Complement-mediated cellular injury. Semin Nephrol 33: 586-601, 2013.
40. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401, 2006.
41. Verma R, Aravind L, Oania R, McDonald WH, Yates JR, 3rd Koonin EV, Deshaies RJ. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298: 611-615, 2002.
42. Yang M, Omura S, Bonifacino JS, Weissman AM. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J Exp Med 187: 835-846, 1998.
43. Zhu J, Sun N, Aoudjit L, Li H, Kawachi H, Lemay S, Takano T. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 73: 556-566, 2008.